Author [ Title] Type Year
Filters: Author is Ansell, Stephen M [Clear All Filters]
Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis. Leuk Res. 2019;81:1-9..
Dacetuzumab plus R-ICE as salvage therapy for patients with DLBCL relapsing after R-CHOP: a randomized, double-blind, placebo-controlled Phase 2b trial. Leuk Lymphoma. 2015:1-24.
Hodgkin Lymphoma: 2020 update on diagnosis, risk-stratification, and management. Am J Hematol. 2020..
Immunologic Autograft Engineering and Survival in Non-Hodgkin's Lymphoma. Biol Blood Marrow Transplant. 2016.